1. Home
  2. CTRE vs KYMR Comparison

CTRE vs KYMR Comparison

Compare CTRE & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareTrust REIT Inc.

CTRE

CareTrust REIT Inc.

HOLD

Current Price

$41.12

Market Cap

9.9B

Sector

Real Estate

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$107.50

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRE
KYMR
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
9.6B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
CTRE
KYMR
Price
$41.12
$107.50
Analyst Decision
Buy
Strong Buy
Analyst Count
10
26
Target Price
$42.40
$107.72
AVG Volume (30 Days)
1.9M
533.7K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
3.44%
N/A
EPS Growth
96.25
N/A
EPS
0.74
N/A
Revenue
$476,393,000.00
$39,211,000.00
Revenue This Year
$5.97
$10.61
Revenue Next Year
$13.39
$8.17
P/E Ratio
$114.33
N/A
Revenue Growth
60.79
N/A
52 Week Low
$32.25
$36.88
52 Week High
$43.62
$130.05

Technical Indicators

Market Signals
Indicator
CTRE
KYMR
Relative Strength Index (RSI) 48.54 50.17
Support Level $35.82 $76.40
Resistance Level $41.83 $120.37
Average True Range (ATR) 0.94 4.47
MACD -0.27 -1.40
Stochastic Oscillator 30.90 33.92

Price Performance

Historical Comparison
CTRE
KYMR

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: